News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
MedPage Today on MSN18h
CDC Expert Resigns From COVID Vax Role; FDA to Probe Abortion Drug; Measles UpdateA top CDC official said she was resigning from her role overseeing updates to the agency's COVID-19 vaccine recommendations ...
2don MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.
Makary was accurate when he said that "most countries have stopped recommending" routine COVID-19 vaccination for children.
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
Health Secretary Robert F. Kennedy Jr. said Covid shots were coming off the childhood vaccine schedule. A memo sent by the ...
In the wake of recent warnings from the Food and Drug Administration (FDA), about half of Americans think vaccines against ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback